ScreeningPort

Fraunhofer Institute for Molecular Biology and Applied Ecology IME

IME ScreeningPort’s mission is to bridge the gap between basic academic research and the life sciences industry in the field of drug discovery and development. With state-of-the-art infrastructure at its location in Hamburg, established processes and innovative technologies, IME-SP positioned itself as a world-leading contract research organization for small-molecule screening, particularly for targets identified by academic partners.

The IME SP directs its efforts onto the development of biological assay systems, high-throughput drug discovery (i.e. high-throughput screening, high-content screening and virtual screening), and the identification of diagnostic biomarkers (including those used for companion diagnostics in preclinical/clinical studies and pharmacological bioinformatics).

Research Areas

Drug Discovery

Biomarker and Translational Research

Enabling Technologies

R&D Information Technologies

Social Bookmarks